ICMR-NIN study links micronutrient deficiencies to higher dementia risk among Indian adults

IMT News Desk
IMT News Desk
· 2 min read
ICMR-NIN study links vitamin D, B2, B6, B12 deficiencies to higher dementia risk among Indian adults, highlighting nutrition as a modifiable factor.

A recent study by the ICMR-National Institute of Nutrition (ICMR-NIN) has found a significant association between micronutrient deficiencies and higher predicted risk of dementia among Indian adults, highlighting nutrition as a potentially modifiable factor in preventing cognitive decline and supporting healthy ageing.

The community-based cross-sectional study assessed 556 adults aged 40- 80 years from rural and urban areas of Telangana using a culturally adapted version of the Cardiovascular Risk Factors, Ageing and Incidence of Dementia (CAIDE) score to evaluate dementia risk and its relationship with micronutrient profiles.

Nearly 40% of participants were classified as having a higher predicted risk of dementia, and individuals in this high-risk group showed significantly poorer nutritional status compared to those with lower risk scores.

Deficiencies of vitamins D, B2, B6 and B12 were markedly more prevalent among those with higher dementia risk, and these participants also had lower dietary diversity, higher consumption of saturated fats and lower intake of unsaturated fats.

Vitamin deficiencies were more common among rural participants than urban residents, pointing to rural-specific vulnerabilities that may contribute to increased dementia risk in those communities.

The findings suggest that diets rich in micronutrients, particularly fruits and vegetables, are associated with a lower burden of dementia risk factors, underscoring the importance of dietary diversity and micronutrient adequacy for brain health.

Dr G Bhanuprakash Reddy, Scientist G at ICMR-NIN and lead investigator, said that as India’s ageing population expands, the number of people living with dementia is expected to rise substantially by 2050, and his study highlights that micronutrient status is closely linked with dementia risk factor burden among Indian adults.

Though the cross-sectional design limits causal inference, the study emphasizes that nutrition, especially micronutrient adequacy and dietary diversity, represents a modifiable factor that can be targeted through public health interventions.

Dr Bharati Kulkarni, Director of ICMR-NIN, said that given limited disease-modifying therapies for dementia, prevention through early identification of risk factors and timely intervention is increasingly important, and nutritional factors, particularly micronutrient status, should be integrated into future dementia prevention strategies.

The study was conducted in collaboration with investigators from the Stanford Center for Innovation in Global Health in the USA and the Karolinska Institute in Sweden, and the findings have been published in The Lancet Regional Health–Southeast Asia.

Read Next

India’s first focused health AI Conclave unites doctors and AI experts
Featured Article
July 10, 2026

India’s first focused health AI Conclave unites doctors and AI experts

• Global Healthcare Academy hosts HAI Conclave 2026, India’s first national platform dedicated to Healthcare and Artificial Intelligence • Landmark Bengaluru conference brings together healthcare leaders and AI experts to explore how Artificial Intelligence can make healthcare faster, safer and more accessible while keeping patients at the centre of every decision The inaugural edition of the HAI Conclave […]
Article by: IMT News Desk
Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026
News
July 10, 2026

Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026

Fischer Medical Ventures Limited (FMVL) has announced that its strategic partner, Nanyang Biologics, has achieved a major international milestone with its AI-powered molecular research platform, NYB.AI, being featured in the opening showcase at NVIDIA GTC Taiwan 2026, ahead of the keynote address by NVIDIA Founder and CEO Jensen Huang. The recognition places NYB.AI among a […]
Article by: IMT News Desk
Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs
News
July 10, 2026

Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs

Indian pharmaceutical companies are expected to report healthy revenue growth in the first quarter of FY27, but margins are likely to compress as sector profitability comes under pressure. In a recent preview note, Goldman Sachs said it anticipates around 185 basis points year-on-year margin decline for the sector in the June quarter, driven primarily by […]
Article by: IMT News Desk
Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue
News
July 10, 2026

Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue

Dr Reddy’s Laboratories has announced a delay in commercial supplies of its semaglutide product after certain batches were found to be out of specification due to an issue with the active pharmaceutical ingredient (API) used in the drug. The company said it has initiated an investigation into the root cause and is taking corrective measures […]
Article by: IMT News Desk